Mitochondrial functional and structural impairment is involved in the antitumor activity of δ-tocotrienol in prostate cancer cells
Authors:
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 160, 376-390
Abstract
No abstract availableKeywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca
This publication has 75 references indexed in Scilit:
- Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem CellsPLOS ONE, 2013
- Mitochondrial‐dependent anticancer activity of δ‐tocotrienol and its synthetic derivatives in HER‐2/neu overexpressing breast adenocarcinoma cellsBioFactors, 2013
- Autophagy is differentially induced in prostate cancer LNCaP, DU145 and PC-3 cells via distinct splicing profiles of ATG5Autophagy, 2013
- Radical Decisions in Cancer: Redox Control of Cell Growth and DeathCancers, 2012
- Mitochondria: In Sickness and in HealthCell, 2012
- Preferential killing of cancer cells with mitochondrial dysfunction by natural compoundsMitochondrion, 2010
- Regulation of OPA1 processing and mitochondrial fusion by m-AAA protease isoenzymes and OMA1Journal of Cell Biology, 2009
- Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cellsJournal of Cell Biology, 2009
- Fission and selective fusion govern mitochondrial segregation and elimination by autophagyThe EMBO Journal, 2008
- Regulation of the mitochondrial dynamin-like protein Opa1 by proteolytic cleavageJournal of Cell Biology, 2007